• Dyne Therapeutics (NASDAQ:DYN) Receives "Buy" Rating from Chardan Capital

    Source: Buzz FX / 01 Mar 2025 11:06:14   America/New_York


    Dyne Therapeutics (NASDAQ:DYN) Receives "Buy" Rating from Chardan Capital Written by MarketBeat March 1, 2025 Share Link copied to clipboard. Dyne Therapeutics ( NASDAQ:DYN - Get Free Report ) 's stock had its "buy" rating reaffirmed by sto
    Read more...
Share on,